Showing results (41-50 of 57) with videos related to
Sort By:
Pageof 6
British Journal of Haematology|October 16, 1999
Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de MoelleN Dhedin, S Giraudier, P Gaulard, et al.British Journal of Haematology|May 1, 2001
Health and functional status of adult recipients 1 year after allogeneic haematopoietic stem cell transplantationG Socié, J Y Mary, H Esperou, et al.Bone Marrow Transplantation|February 1, 1996
Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, G Leverger, T Leblanc, et al.Bone Marrow Transplantation|July 1, 1996
Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT)N C Gorin, M Labopin, L Fouillard, et al.Bone Marrow Transplantation|May 29, 2007
Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignanciesC Ferry, G Gemayel, V Rocha, et al.Leukemia|September 16, 1998
Influence of CD34 cell selection on the incidence of mixed chimaerism and minimal residual disease after allogeneic unrelated donor transplantationG Socié, J M Cayuela, B Raynal, et al.Bone Marrow Transplantation|January 7, 1998
Allogeneic bone marrow transplantation for high-risk acute lymphoblastic leukemia in first remission: long-term results for 42 patients conditioned with an intensified regimen (TBI, high-dose Ara-C and melphalan)E Deconinck, J Y Cahn, N Milpied, et al.Bone Marrow Transplantation|November 5, 2003
Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)F Millot, H Esperou, P Bordigoni, et al.Bone Marrow Transplantation|July 27, 2005
Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemiaC Cordonnier, S Maury, H Esperou, et al.Blood|June 11, 1999
Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMTA Cohen, A Rovelli, B Bakker, et al.Pageof 6